FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Published at www.nejm.org February 12, 2007 (10.1056/NEJMe068306)

	PDF Animation Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Notice: This editorial was published at www.nejm.org on February 12, 2007. It will appear in the March 8 issue of the Journal.

Click on "PDF" for the full text.

This article has been cited by other articles:

• Ormiston, J. A., Webster, M. W.I., Schwartz, R. S., Gladding, P., Stewart, J. T., Kay, I. P., Ruygrok, P. N., Hatrick, R. (2009). Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus-Eluting Stent: Traditional Pre-Clinical Safety End Points Failed to Predict 6-Month Clinical Angiographic Results. J Am Coll Cardiol Intv 2: 1017-1024 [Abstract] [Full Text]  
• Bhatt, D. L. (2009). Prasugrel in Clinical Practice. NEJM 361: 940-942 [Full Text]  
• Herdeg, C., Gohring-Frischholz, K., Haase, K. K., Geisler, T., Zurn, C., Hartmann, U., Wohrle, J., Nusser, T., Dippon, J., May, A. E., Gawaz, M. (2009). Catheter-Based Delivery of Fluid Paclitaxel for Prevention of Restenosis in Native Coronary Artery Lesions After Stent Implantation. Circ Cardiovasc Interv 2: 294-301 [Abstract] [Full Text]  
• To, A. C.Y., Armstrong, G., Zeng, I., Webster, M. W.I. (2009). Noncardiac Surgery and Bleeding After Percutaneous Coronary Intervention. Circ Cardiovasc Interv 2: 213-221 [Abstract] [Full Text]  
• Carlsson, J., James, S. K., Lindback, J., Schersten, F., Nilsson, T., Stenestrand, U., Lagerqvist, B., for the SCAAR (Swedish Coronary Angiography and An, (2009). Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria. J Am Coll Cardiol 53: 1389-1398 [Abstract] [Full Text]  
• Samady, H., McDaniel, M., Veledar, E., De Bruyne, B., Pijls, N. H., Fearon, W. F., Vaccarino, V. (2009). Baseline Fractional Flow Reserve and Stent Diameter Predict Optimal Post-Stent Fractional Flow Reserve and Major Adverse Cardiac Events After Bare-Metal Stent Deployment. J Am Coll Cardiol Intv 2: 357-363 [Abstract] [Full Text]  
• (2009). Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.. Circ Cardiovasc Interv 2: 35-42  
• Kelbaek, H., Terkelsen, C. J., Helqvist, S., Lassen, J. F., Clemmensen, P., Klovgaard, L., Kaltoft, A., Engstrom, T., Botker, H. E., Saunamaki, K., Krusell, L. R., Jorgensen, E., Hansen, H.-H. T., Christiansen, E. H., Ravkilde, J., Kober, L., Kofoed, K. F., Thuesen, L. (2008). Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.. J Am Coll Cardiol 51: 899-905 [Abstract] [Full Text]  
• Applegate, R. J., Sacrinty, M. T., Kutcher, M. A., Santos, R. M., Gandhi, S. K., Baki, T. T., Little, W. C. (2008). "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.. J Am Coll Cardiol 51: 607-614 [Abstract] [Full Text]  
• Egashira, K., Nakano, K., Ohtani, K., Funakoshi, K., Zhao, G., Ihara, Y., Koga, J.-i., Kimura, S., Tominaga, R., Sunagawa, K. (2007). Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys. Arterioscler. Thromb. Vasc. Bio. 27: 2563-2568 [Abstract] [Full Text]  
• Holmes, D. R. Jr, Kereiakes, D. J., Laskey, W. K., Colombo, A., Ellis, S. G., Henry, T. D., Popma, J. J., Serruys, P. W.J.C., Kimura, T., Williams, D. O., Windecker, S., Krucoff, M. W. (2007). Thrombosis and Drug-Eluting Stents: An Objective Appraisal. J Am Coll Cardiol 50: 109-118 [Abstract] [Full Text]  
• (2007). JournalScan. Heart 93: 890-892 [Full Text]  
• Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G.B. J., Weintraub, W. S., the COURAGE Trial Research Group, (2007). Optimal Medical Therapy with or without PCI for Stable Coronary Disease. NEJM 356: 1503-1516 [Abstract] [Full Text]  
• (2007). Latest Findings on Stents. JWatch General 2007: 1-1 [Full Text]